# RYTELO
> **NDA217779** · New Drug Application · Sponsor: GERON · Approved 2024-06-06
## Drug
- **FDA Application Number:** NDA217779
- **Application type:** New Drug Application
- **Brand name:** RYTELO
- **Generic name:** IMETELSTAT SODIUM
- **Active ingredients:** IMETELSTAT SODIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GERON
- **Manufacturer:** Geron Corporation
- **First approval:** 2024-06-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217779)
---
*AI Analytics · CC0 1.0*